Bayer HealthCare LLC Animal Health Division, Shawnee, Kan., received approval from the Food and Drug Administration (FDA) to market ProstaMate (dinoprost tromethamine) and OvaCyst (gonadorelin diacetate tetrahydrate) reproduction support as prescribed by veterinarians. ProstaMate is indicated for use in cattle, swine and mares; OvaCyst for use in dairy cattle.
Two of Bayer’s newest products were acquired through the Teva acquisition, ProstaMate, and OvaCyst. ProstaMate sterile solution is indicated for intramuscular use for estrus synchronization, treatment of unobserved estrus and chronic endometritis in cattle; for parturition induction in swine; and for controlling the timing of estrus in estrous cycling mares and clinically anestrous mares that have a corpus luteum. OvaCyst sterile solution is indicated for the treatment of cystic ovaries in dairy cattle. OvaCyst initiates the release of normal physiological levels of endogenous LH (luteinizing hormone) to cause ovulation and luteinization.
ProstaMate and OvaCyst are available through Bayer-approved distributors.
Copyright 1995-2014. High
Plains Publishers, Inc. All rights reserved. Any republishing
of these pages, including electronic reproduction of the editorial archives
or classified advertising, is strictly prohibited. If you have questions or
comments you can reach us at
High Plains Journal
1500 E. Wyatt Earp Blvd., P.O. Box 760, Dodge City, KS 67801
or call 1-800-452-7171. Email: